Conventional fractionation should not be the standard of care for T2 glottic cancer.
Name:
s13014-017-0915-8.pdf
Size:
482.0Kb
Format:
PDF
Description:
Open access full text article
Authors
Dixon, LynneDouglas, C
Shaukat, Shazril Imran
Garcez, Kate
Lee, Lip W
Sykes, Andrew J
Thomson, David J
Slevin, Nicholas J
Affiliation
Department of Clinical Oncology, The Christie NHS Foundation Trust, Wilmslow Road, ManchesterIssue Date
2017-11-14
Metadata
Show full item recordAbstract
The aim of this study was to report outcomes and late toxicity following hypofractionated accelerated radiotherapy for T2 glottic cancers. We highlight the importance of hypofractionated treatments with shorter overall treatment times, in improving outcomes for T2 glottic cancers. We also compare the biologically effective dose of hypofractionated regimes, with conventional fractionation.Citation
Conventional fractionation should not be the standard of care for T2 glottic cancer. 2017, 12 (1):178 Radiat OncolJournal
Radiation OncologyDOI
10.1186/s13014-017-0915-8PubMed ID
29137654Type
ArticleLanguage
enISSN
1748-717Xae974a485f413a2113503eed53cd6c53
10.1186/s13014-017-0915-8